Virtu Financial’s Crescent Biopharma CBIO Stock Holding History

Virtu Financial’s Portfolio CBIO Stock Details CBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-363	Closed	-$8K	–	1682
2025 Q1	$8K	Buy	+363	New	+$9.71K	﹤0.01%	1207
2024 Q4	–	Sell	-195	Closed	-$3K	–	1719
2024 Q3	$3K	Buy	+195	New	+$4.09K	﹤0.01%	1260
2024 Q1	–	Sell	-343	Closed	-$81K	–	1656
2023 Q4	$81K	Buy	+343	New	+$53.3K	0.01%	1071
2021 Q4	–	Sell	-541	Closed	-$119K	–	1886
2021 Q3	$119K	Buy	+541	New	+$115K	0.01%	1087
2021 Q1	–	Sell	-128	Closed	-$48K	–	1767
2020 Q4	$48K	Buy	+128	New	+$44.9K	0.01%	1236
2018 Q1	–	Sell	-125	Closed	-$210K	–	2191
2017 Q4	$210K	Buy	+125	New	+$165K	0.01%	1628

Other funds holding CBIO

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return